Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
deals
ipo
2
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
2
×
san francisco top stories
startups
abbvie
acetylon pharmaceuticals
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
ambys medicines
amunix
anirvan ghosh
astrazeneca
biogen
bluerock therapeutics
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cell therapy
cerovene
clinical trials
constellation pharmaceuticals
covid-19
crispr
deerfield management
detroit blog main
detroit top stories
What
deal
2
×
medicines
2
×
acquisitions
aiming
ambys
announced
big
bio
biotech
ceo
collabs
control
covid
daniel
deadly
debuted
diseases
formed
future
gilead
gilead’s
help
introduce
ipo
launch
liver
make
month
new
o’day
plans
roundup
sciences
startup
takeda
today
transformative
treatments
unusual
variety
Language
unset
Current search:
medicines
×
ipo
×
" san francisco blog main "
×
deal
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?